Self-regulation of agonist activity at the Y receptors

Peptides

Volumn 28, Issue 2, 2007, Pages 203-213

  Parker, S L ^a   Parker, M S ^b   Sah, R ^c   Balasubramaniam, A ^c   Sallee, F R ^c  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF MEMPHIS   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Agonist crossreactivity; Receptor blockade; Receptor internalization; Receptor signaling

Indexed keywords

GONADORELIN RECEPTOR; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR; NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE Y2 RECEPTOR; NEUROPEPTIDE Y4 RECEPTOR; PANCREAS POLYPEPTIDE; PEPTIDE YY;

ANIMAL CELL; ARTICLE; AUTOREGULATION; CONTROLLED STUDY; ENDOCYTOSIS; FOREBRAIN; HORMONE RECEPTOR INTERACTION; INTERNALIZATION; NEUROENDOCRINOLOGY; NONHUMAN; PRIORITY JOURNAL; SYNAPSE;

ADENYLATE CYCLASE; ANIMALS; CHO CELLS; CRICETINAE; CRICETULUS; ENDOCYTOSIS; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HUMANS; RATS; RECEPTORS, NEUROPEPTIDE Y;

EID: 33846641309     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2006.07.032     Document Type: Article

References (57)

1. Aakerlund L., Gether U., Fuhlendorff J., Schwartz T.W., and Thastrup O. Y1 receptors for neuropeptide Y are coupled to mobilization of intracellular calcium and inhibition of adenylate cyclase. FEBS Lett 260 (1990) 73-78
2. Allen Y.S., Adrian T.E., Allen J.M., Tatemoto K., Crow T.J., Bloom S.R., et al. Neuropeptide Y distribution in the rat brain. Science 221 (1983) 877-879
3. Balasubramaniam A., Dhawan V.C., Mullins D.E., Chance W.T., Sheriff S., Guzzi M., et al. Highly selective and potent neuropeptide Y (NPY) Y1 receptor antagonists based on [Pro(30), Tyr(32), Leu(34)]NPY(28-36)-NH2 (BW1911U90). J Med Chem 44 (2001) 1479-1482
4. Bard J.A., Walker M.W., Branchek T.A., and Weinshank R.L. Cloning and functional expression of a human Y4 subtype receptor for pancreatic polypeptide, neuropeptide Y, and peptide YY. J Biol Chem 270 (1995) 26762-26765
5. Beck-Sickinger A.G., Wieland H.A., Wittneben H., Willim K.D., Rudolf K., and Jung G. Complete l-alanine scan of neuropeptide Y reveals ligands binding to Y1 and Y2 receptors with distinguished conformations. Eur J Biochem 225 (1994) 947-958
6. Berglund M.M., Schober D.A., Statnick M.A., McDonald P.H., and Gehlert D.R. The use of bioluminescence resonance energy transfer 2 to study neuropeptide Y receptor agonist-induced beta-arrestin 2 interaction. J Pharmacol Exp Ther 306 (2003) 147-156
7. Besterman J.M., Airhart J.A., Woodworth R.C., and Low R.B. Exocytosis of pinocytosed fluid in cultured cells: kinetic evidence for rapid turnover and compartmentation. J Cell Biol 91 (1981) 716-727
8. Bonini J.A., Jones K.A., Adham N., Forray C., Artymyshyn R., Durkin M.M., et al. Identification and characterization of two G protein-coupled receptors for neuropeptide FF. J Biol Chem 275 (2000) 39324-39331
9. Campbell R.E., Smith M.S., Allen S.E., Grayson B.E., Ffrench-Mullen J.M., and Grove K.L. Orexin neurons express a functional pancreatic polypeptide Y4 receptor. J Neurosci 23 (2003) 1487-1497
10. Chang R.S., Lotti V.J., Chen T.B., Cerino D.J., Kling P.J., and Neuropeptide Y. (NPY) binding sites in rat brain labeled with 125I-Bolton-Hunter NPY: comparative potencies of various polypeptides on brain NPY binding and biological responses in the rat vas deferens. Life Sci 37 (1985) 2111-2122
11. Dube M.G., Horvath T.L., Kalra P.S., and Kalra S.P. Evidence of NPY Y5 receptor involvement in food intake elicited by orexin A in sated rats. Peptides 21 (2000) 1557-1560
12. Dumont Y., Cadieux A., Pheng L.H., Fournier A., St-Pierre S., and Quirion R. Peptide YY derivatives as selective neuropeptide Y/peptide YY Y1 and Y2 agonists devoided of activity for the Y3 receptor sub-type. Brain Res Mol Brain Res 26 (1994) 320-324
13. Ekstrand A.J., Cao R., Bjorndahl M., Nystrom S., Jonsson-Rylander A.C., Hassani H., et al. Deletion of neuropeptide Y (NPY) 2 receptor in mice results in blockage of NPY-induced angiogenesis and delayed wound healing. Proc Natl Acad Sci U S A 100 (2003) 6033-6038
14. Freitag C., Svendsen A.B., Feldthus N., Lossl K., and Sheikh S.P. Coupling of the human Y2 receptor for neuropeptide Y and peptide YY to guanine nucleotide inhibitory proteins in permeabilized SMS-KAN cells. J Neurochem 64 (1995) 643-650
15. Gehlert D.R., Beavers L.S., Johnson D., Gackenheimer S.L., Schober D.A., and Gadski R.A. Expression cloning of a human brain neuropeptide Y Y2 receptor. Mol Pharmacol 49 (1996) 224-228
16. Gehlert D.R., Schober D.A., Beavers L., Gadski R., Hoffman J.A., Smiley D.L., et al. Characterization of the peptide binding requirements for the cloned human pancreatic polypeptide-preferring receptor. Mol Pharmacol 50 (1996) 112-118
17. Gicquiaux H., Lecat S., Gaire M., Dieterlen A., Mely Y., Takeda K., et al. Rapid internalization and recycling of the human neuropeptide Y Y(1) receptor. J Biol Chem 277 (2002) 6645-6655
18. Gigoux V., Escrieut C., Fehrentz J.A., Poirot S., Maigret B., Moroder L., et al. Arginine 336 and asparagine 333 of the human cholecystokinin-A receptor binding site interact with the penultimate aspartic acid and the C-terminal amide of cholecystokinin. J Biol Chem 274 (1999) 20457-20464
19. Gobbi M., Gariboldi M., Piwko C., Hoyer D., Sperk G., and Vezzani A. Distinct changes in peptide YY binding to, and mRNA levels of, Y1 and Y2 receptors in the rat hippocampus associated with kindling epileptogenesis. J Neurochem 70 (1998) 1615-1622
20. Heuser J.E., and Anderson R.G. Hypertonic media inhibit receptor-mediated endocytosis by blocking clathrin-coated pit formation. J Cell Biol 108 (1989) 389-400
21. Hilal-Dandan R., Villegas S., Gonzalez A., and Brunton L.L. The quasi-irreversible nature of endothelin binding and G protein-linked signaling in cardiac myocytes. J Pharmacol Exp Ther 281 (1997) 267-273
22. Kane J.K., Parker S.L., Matta S.G., Fu Y., Sharp B.M., and Li M.D. Nicotine up-regulates expression of orexin and its receptors in rat brain. Endocrinology 141 (2000) 3623-3629
23. Kane J.K., Tanaka H., Parker S.L., Yanagisawa M., and Li M.D. Sensitivity of orexin-A binding to phospholipase C inhibitors, neuropeptide Y, and secretin. Biochem Biophys Res Commun 272 (2000) 959-965
24. Keire D.A., Bowers C.W., Solomon T.E., and Reeve Jr. J.R. Structure and receptor binding of PYY analogs. Peptides 23 (2002) 305-321
25. Leblanc P., L'Heritier A., Rasolonjanahary R., Kordon C., and Neuropeptide. Y enhances LHRH binding to rat gonadotrophs in primary culture. Neuropeptides 26 (1994) 87-92
26. Lerch M., Gafner V., Bader R., Christen B., Folkers G., and Zerbe O. Bovine pancreatic polypeptide (bPP) undergoes significant changes in conformation and dynamics upon binding to DPC micelles. J Mol Biol 322 (2002) 1117-1133
27. Lerch M., Mayrhofer M., and Zerbe O. Structural similarities of micelle-bound peptide YY (PYY) and neuropeptide Y (NPY) are related to their affinity profiles at the Y receptors. J Mol Biol 339 (2004) 1153-1168
28. McDonald J.K., Han C., Noe B.D., and Abel P.W. High levels of NPY in rabbit cerebrospinal fluid and immunohistochemical analysis of possible sources. Brain Res 463 (1988) 259-267
29. McLean L.R., Baron B.M., Buck S.H., and Krstenansky J.L. Lipid and membrane interactions of neuropeptide Y. Biochim Biophys Acta 1024 (1990) 1-4
30. Minneman K.P., Weiland G.A., and Molinoff P.B. A comparison of the beta-adrenergic receptor of the turkey erythrocyte with mammalian beta1 and beta2 receptors. Molec Pharmacol 17 (1980) 1-7
31. Monaghan D.T., Bridges R.J., and Cotman C.W. The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system. Annu Rev Pharmacol 29 (1989) 365-402
32. Munson P.J., and Rodbard D. LIGAND: a versatile computerized approach for characterization of ligand-binding proteins. Anal Biochem 107 (1980) 220-239
33. Orlandi P.A., and Fishman P.H. Filipin-dependent inhibition of cholera toxin: evidence for toxin internalization and activation through caveolae-like domains. J Cell Biol 141 (1998) 905-915
34. Parker E.M., Babij C.K., Balasubramaniam A., Burrier R.E., Guzzi M., Hamud F., et al. GR231118 (1229U91) and other analogues of the C-terminus of neuropeptide Y are potent neuropeptide Y Y1 receptor antagonists and neuropeptide Y Y4 receptor agonists. Eur J Pharmacol 349 (1998) 97-105
35. Parker M.S., Berglund M.M., Lundell I., and Parker S.L. Blockade of pancreatic polypeptide-sensitive neuropeptide Y (NPY) receptors by agonist peptides is prevented by modulators of sodium transport, Implications for receptor signaling and regulation. Peptides 22 (2001) 887-898
36. Parker M.S., Lundell I., and Parker S.L. Pancreatic polypeptide receptors: affinity, sodium sensitivity and stability of agonist binding. Peptides 23 (2002) 291-303
37. Parker M.S., Sah R., Sheriff S., Balasubramaniam A., and Parker S.L. Internalization of cloned pancreatic polypeptide receptors is accelerated by all types of Y4 agonists. Regulatory Peptides 132 (2005) 91-101
38. Parker S.L., Kalra S.P., Crowley W.R., and Neuropeptide. Y modulates the binding of a gonadotropin-releasing hormone (GnRH) analog to anterior pituitary GnRH receptor sites. Endocrinology 128 (1991) 2309-2316
39. Parker S.L., Parker M.S., and Crowley W.R. Characterization of Y1 Y2 and Y5 subtypes of the neuropeptide Y (NPY) receptor in rabbit kidney. Sensitivity of ligand binding to guanine nucleotides and phospholipase C inhibitors. Regul Pept 75-76 (1998) 127-143
40. Parker S.L., Parker M.S., Sweatman T., and Crowley W.R. Characterization of G protein and phospholipase C-coupled agonist binding to the Y1 neuropeptide Y receptor in rat brain: sensitivity to G protein activators and inhibitors and to inhibitors of phospholipase C. J Pharmacol Exp Ther 286 (1998) 382-391
41. Parker S.L., and Parker M.S. Ligand association with the rabbit kidney and brain Y1, Y2 and Y5-like neuropeptide Y (NPY) receptors shows large subtype-related differences in sensitivity to chaotropic and alkylating agents. Regul Pept 87 (2000) 59-72
42. Parker S.L., Kane J.K., Parker M.S., Berglund M.M., Lundell I.A., and Li M.D. Cloned neuropeptide Y (NPY) Y1 and pancreatic polypeptide Y4 receptors expressed in Chinese hamster ovary cells show considerable agonist-driven internalization, in contrast to the NPY Y2 receptor. Eur J Biochem 268 (2001) 877-886
43. Parker S.L., Parker M.S., Kane J.K., and Berglund M.M. A pool of Y2 neuropeptide Y receptors activated by modifiers of membrane sulfhydryl or cholesterol balance. Eur J Biochem 269 (2002) 2315-2322
44. Parker S.L., Parker M.S., Lundell I., Balasubramaniam A., Buschauer A., Kane J.K., et al. Agonist internalization by cloned Y1 neuropeptide Y (NPY) receptor in Chinese hamster ovary cells shows strong preference for NPY, endosome- linked entry and fast receptor recycling. Regul Pept 107 (2002) 49-62
45. Parker S.L., Parker M.S., Buschauer A., and Balasubramaniam A. Ligand internalization by cloned neuropeptide Y Y5 receptors excludes Y2 and Y4 receptor-selective peptides. Eur J Pharmacol 474 (2003) 31-42
46. Parker S.L., Parker M.S., Sah R., and Sallee F. Angiogenesis and rhodopsin-like receptors: a role for N-terminal acidic residues?. Biochem Biophys Res Commun 335 (2005) 983-992
47. Patacchini R., Quartara L., Rovero P., Goso C., and Maggi C.A. Role of C-terminal amidation on the biological activity of neurokinin A derivatives with agonist and antagonist properties. J Pharmacol Exp Ther 264 (1993) 17-21
48. Roettger B.F., Pinon D.I., Burghardt T.P., and Miller L.J. Regulation of lateral mobility and cellular trafficking of the CCK receptor by a partial agonist. Am J Physiol 276 (1999) C539-C547
49. Rose J.M., and Audus K.L. Receptor-mediated angiotensin II transcytosis by brain microvessel endothelial cells. Peptides 19 (1998) 1023-1030
50. Sah R., Balasubramaniam A., Parker M.S., Sallee F., Parker S.L., and Neuropeptide. Y as a partial agonist of the Y1 receptor. Eur J Pharmacol 525 (2005) 60-68
51. Schober D.A., Van Abbema A.M., Smiley D.L., Bruns R.F., and Gehlert D.R. The neuropeptide Y Y1 antagonist, 1229U91, a potent agonist for the human pancreatic polypeptide-preferring (NPY Y4) receptor. Peptides 19 (1998) 537-542
52. Schwarzer C., Kofler N., and Sperk G. Up-regulation of neuropeptide Y-Y2 receptors in an animal model of temporal lobe epilepsy. Mol Pharmacol 53 (1998) 6-13
53. Sherwood N.M., Krueckl S.L., and McRory J.E. The origin and function of the pituitary adenylate cyclase-activating polypeptide (PACAP)/glucagon superfamily. Endocr Rev 21 (2000) 619-670
54. Thompson A.C., Justice Jr. J.B., and McDonald J.K. Quantitative microdialysis of neuropeptide Y. J Neurosci Methods 60 (1995) 189-198
55. Volkoff H., and Peter R.E. Interactions between orexin A, NPY and galanin in the control of food intake of the goldfish Carassius auratus. Regul Pept 101 (2001) 59-72
56. Vu Hai M.T., Lescop P., Loosfelt H., and Ghinea N. Receptor-mediated transcytosis of follicle-stimulating hormone through the rat testicular microvasculature. Biol Cell 96 (2004) 133-144
57. Zukowska-Grojec Z., Karwatowska-Prokopczuk E., Fisher T.A., and Ji H. Mechanisms of vascular growth-promoting effects of neuropeptide Y: role of its inducible receptors. Regul Pept 75-76 (1998) 231-238